Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_18487 | 36 | 0.75 | Mlig455_004379 | Neo: - Age: - |
Mlig455_004379 {REF} {Length: 1362} {RNA1310_54189} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.691 | 1.275 | 0.99979 | 1.00000 | |
RegionR2 | 0.79 | 1.275 | 0.57427 | 0.93232 | |
RegionR3 | 1.675 | 1.275 | 0.23355 | 0.77562 | |
RegionR4 | 2.381 | 1.275 | 0.18197 | 0.45300 | |
RegionR5 | -0.028 | 1.275 | 0.76426 | 1.00000 | |
RegionR6 | -0.343 | 1.275 | 0.79932 | 1.00000 | |
RegionR7 | -2.395 | 1.275 | 0.99948 | 1.00000 | |
RegionR8 | -1.388 | 1.275 | 0.99980 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.993 | 1.275 | 0.99996 | 1.00000 | |
RegenerationR2 | 0.972 | 1.275 | 0.37885 | 0.80074 | |
RegenerationR3 | -1.609 | 1.275 | 0.17291 | 0.60856 | |
RegenerationR4 | -1.156 | 1.275 | 0.43038 | 0.83064 | |
RegenerationR5 | -0.647 | 1.275 | 0.76473 | 0.97693 | |
RegenerationR6 | 0.197 | 1.275 | 0.90362 | 1.00000 | |
RegenerationBL | -2.196 | 1.275 | 0.99971 | 1.00000 | |
RegenerationTP | 2.517 | 1.275 | 0.36762 | 0.80563 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_18487 | 36 | 0.75 | Mlig455_004379 | Neo: - Age: - |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_004379 {REF} {Length: 1362} {RNA1310_54189} | |
2. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 3.574 | - | - | 0.833 | 0.977 | 0.935 | 0.829 | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
3. | MligTC455_45019 | 64 | 1.33 | Mlig455_009383, Mlig455_036937 | Neo: - Age: - |
WSCD2 | 3.463 | - | - | 0.766 | 0.921 | 0.967 | 0.809 | Mlig455_009383 {REF} {Length: 854} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} Mlig455_036937 {REF} {Length: 858} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} |
4. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
3.409 | - | - | 0.804 | 0.939 | 0.965 | 0.701 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
5. | MligTC455_19266 | 1038 | 21.61 | Mlig455_004528, Mlig455_028530 | Neo: - Age: - Region-specific R2: 2.706 Region-enriched R2: 1.766/0.00005 |
NCALD | 3.37 | - | - | 0.750 | 0.958 | 0.767 | 0.895 | Mlig455_004528 {REF} {Length: 3958} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_14564} {RNA1310_18405, RNA1509_14564} {RNA1509_14564, RNA815_10180.1} Mlig455_028530 {REF} {Length: 3453} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_13995, RNA1509_14564, RNA1509_30926} {RNA1310_18405, RNA1509_13995, RNA1509_30926} {RNA1509_13995, RNA1509_30926, RNA815_10180.1} |
6. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
3.304 | - | - | 0.811 | 0.972 | 0.789 | 0.732 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
7. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
3.273 | - | - | 0.838 | 0.955 | 0.765 | 0.715 | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} | |
8. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.257 | - | - | 0.732 | 0.855 | 0.950 | 0.720 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
9. | MligTC455_20091 | 41 | 0.85 | Mlig455_053591 | Neo: - Age: - |
TNN | 3.238 | - | - | 0.769 | 0.976 | 0.746 | 0.747 | Mlig455_053591 {REF} {Length: 1556} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.6]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=105, Expect=8e-25]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=102, Expect=9e-24]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=99.4, Expect=7e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.8, Expect=4e-23]} {Dmel: FBgn0050280, CG30280, [Score=108, Expect=1e-27]} {Celegans: WBGene00016769, C49C8.5, [Score=46.2, Expect=1e-05]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=6e-28]} {RNA1310_44715} {RNA815_35355} |
10. | MligTC455_42037 | 1931 | 40.23 | Mlig455_063391 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.444 Region-specific R2: 2.479 Region-enriched R2: 1.442/0.00136 |
3.221 | - | - | 0.756 | 0.956 | 0.709 | 0.800 | Mlig455_063391 {REF} {Length: 1482} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1310_24553, RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236, RNA815_11766} | |
11. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 3.183 | - | - | 0.741 | 0.967 | 0.763 | 0.712 | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
12. | MligTC455_29508 | 144 | 3 | Mlig455_003167 | Neo: - |
2.749 | - | - | - | 0.950 | 0.931 | 0.868 | Mlig455_003167 {REF} {Length: 1270} {Pfam: Interferon-induced 6-16 family [PF06140.15, score=24.5]} {RNA1509_46297} {RNA1310_35782} {RNA815_17641.2} | |
13. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
2.749 | - | - | 0.847 | 0.964 | 0.938 | - | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
14. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
2.748 | - | - | 0.940 | 0.825 | 0.983 | - | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
15. | MligTC455_15948 | 25 | 0.51 | Mlig455_007630 | Neo: - Age: - |
2.747 | - | - | 0.839 | 0.933 | 0.975 | - | Mlig455_007630 {REF} {Length: 1759} {Pfam: WSC domain [PF01822.21, score=54.5]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-07]} {RNA1509_57286} {RNA1310_33352.2} {RNA815_14158.1} | |
16. | MligTC455_34498 | 36 | 0.75 | Mlig455_029862 | Neo: - Age: - |
NPLOC4 | 2.741 | - | - | 0.815 | 0.952 | 0.974 | - | Mlig455_029862 {REF} {Length: 1491} {TRANSSPLICED} {Pfam: NPL4 family, putative zinc binding region [PF05020.17, score=77.9]} {Human: ENSG00000182446, NPLOC4, NPL4 homolog, ubiquitin recognition factor, [Score=98.2, Expect=1e-21]} {Mouse: ENSMUSG00000039703, Nploc4, NPL4 homolog, ubiquitin recognition factor, [Score=102, Expect=3e-23]} {Celegans: WBGene00019121, npl-4.2, NPL (Yeast Nuclear Protein Localization) homolog, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_5277_0_1, dd_Smed_v6_5277_0_1, [Score=102, Expect=1e-23]} {RNA1509_6797} {RNA1310_13992} {RNA815_5567} |
17. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
2.738 | - | - | 0.814 | 0.946 | 0.978 | - | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
18. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 2.736 | - | - | 0.843 | 0.942 | 0.951 | - | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
19. | MligTC455_32908 | 97 | 2.02 | Mlig455_064081 | Neo: - Age: - |
2.731 | - | - | 0.818 | 0.946 | 0.967 | - | Mlig455_064081 {REF} {Length: 578} {NoTransDecoderORF} {RNA1310_91407} {RNA815_49815} | |
20. | MligTC455_20722 | 36 | 0.74 | Mlig455_001696, Mlig455_066078, Mlig455_066120 | Neo: - Age: - |
2.722 | - | - | 0.896 | 0.979 | 0.847 | - | Mlig455_001696 {REF} {Length: 1535} {RNA1310_134737} {RNA815_57224} Mlig455_066078 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_134737} {RNA815_57224} Mlig455_066120 {REF} {Length: 1438} {Pfam: Glycine rich protein [PF12810.9, score=25.9]} {RNA1310_134737} {RNA815_57224} |
|
21. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 2.72 | - | - | 0.866 | 0.955 | 0.899 | - | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
22. | MligTC455_49490 | 48 | 1 | Mlig455_054769 | Neo: - Age: - |
2.701 | - | - | 0.803 | 0.958 | 0.940 | - | Mlig455_054769 {REF} {Length: 1663} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
23. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
2.67 | - | - | 0.891 | 0.966 | - | 0.813 | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
24. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
2.651 | - | - | 0.782 | 0.960 | 0.909 | - | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
25. | MligTC455_26392 | 64 | 1.33 | Mlig455_001758 | Neo: - Age: - Region-enriched R4: 4.334/0.04740 |
PLD1 | 2.649 | - | - | 0.797 | 0.882 | 0.970 | - | Mlig455_001758 {REF} {Length: 4484} {Pfam: PLD-like domain [PF13091.8, score=36.1]; Phospholipase D Active site motif [PF00614.24, score=31.9]} {Human: ENSG00000075651, PLD1, phospholipase D1, [RH, Score=290, Expect=1e-86]} {Mouse: ENSMUSG00000027695, Pld1, phospholipase D1, [RH, Score=296, Expect=7e-89]} {Dmel: FBgn0033075, Pld, Phospholipase D, [RH, Score=241, Expect=1e-68]} {Celegans: WBGene00004040, pld-1, PhosphoLipase D; Phospholipase D, [RH, Score=248, Expect=9e-71]} {Smed: dd_Smed_v6_61149_0_1, dd_Smed_v6_61149_0_1, [RH, Score=247, Expect=2e-76]} {RNA1509_57028} {RNA1310_1982, RNA1509_57028} {RNA1509_57028, RNA815_17806} |
26. | MligTC455_21580 | 101 | 2.11 | Mlig455_032452 | Neo: - Age: - |
WSCD2 | 2.643 | - | - | 0.752 | 0.937 | 0.954 | - | Mlig455_032452 {REF} {Length: 945} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=3e-07]; ENSG00000179314, WSCD1, WSC domain containing 1, [Score=51.2, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.8, Expect=9e-08]} {RNA1310_78298} {RNA815_49767} |
27. | MligTC455_22150 | 189 | 3.94 | Mlig455_054947 | Neo: - |
XDH | 2.64 | - | - | - | 0.866 | 0.962 | 0.812 | Mlig455_054947 {REF} {Length: 5481} {Pfam: Molybdopterin-binding domain of aldehyde dehydrogenase [PF02738.20, score=346.4]; [2Fe-2S] binding domain [PF01799.22, score=95.7]; FAD binding domain in molybdopterin dehydrogenase [PF00941.23, score=91.5]; CO dehydrogenase flavoprotein C-terminal domain [PF03450.19, score=51.5]; Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain [PF01315.24, score=47.3]; 2Fe-2S iron-sulfur cluster binding domain [PF00111.29, score=25.1]} {Human: ENSG00000158125, XDH, xanthine dehydrogenase, [Score=476, Expect=9e-146]} {Mouse: ENSMUSG00000024066, Xdh, xanthine dehydrogenase, [Score=471, Expect=4e-144]; ENSMUSG00000079554, Aox2, aldehyde oxidase 2, [Score=457, Expect=7e-139]; ENSMUSG00000063558, Aox1, aldehyde oxidase 1, [Score=456, Expect=1e-138]; ENSMUSG00000038242, Aox4, aldehyde oxidase 4, [Score=449, Expect=5e-136]} {Dmel: FBgn0267408, AOX1, Aldehyde oxidase 1, [Score=640, Expect=0.0]} {Celegans: WBGene00010083, xhd-1, [Score=485, Expect=1e-149]} {RNA1509_325, RNA1509_38160} {RNA1310_1603.1, RNA1509_38160} {RNA1509_38160, RNA815_224.2} |
28. | MligTC455_32685 | 505 | 10.53 | Mlig455_057075 | Neo: - Age: Up-Down-Up |
2.637 | - | - | - | 0.952 | 0.906 | 0.779 | Mlig455_057075 {REF} {Length: 7466} {Pfam: REJ domain [PF02010.17, score=62.8]} {RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150} {RNA1310_402.1, RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150} {RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150, RNA815_93.1} | |
29. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 2.631 | - | - | 0.842 | 0.964 | 0.825 | - | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
30. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 2.616 | - | - | 0.842 | 0.958 | - | 0.816 | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
31. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
2.615 | - | - | 0.824 | 0.960 | 0.831 | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
32. | MligTC455_47415 | 204 | 4.25 | Mlig455_065682 | Neo: Int S/G2/M Age: - |
2.598 | - | - | - | 0.871 | 0.958 | 0.769 | Mlig455_065682 {REF} {Length: 697} {NoTransDecoderORF} {RNA1509_49419} {RNA1310_93693} {RNA815_1595} | |
33. | MligTC455_18920 | 299 | 6.22 | Mlig455_052039 | Neo: - Age: Down-Up-Down Region-enriched R8: 3.175/0.01587 |
RTN4R | 2.592 | - | - | - | 0.961 | 0.768 | 0.863 | Mlig455_052039 {REF} {Length: 1911} {Pfam: Leucine rich repeat [PF13855.8, score=113.0]; Leucine Rich repeats (2 copies) [PF12799.9, score=46.5]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=24.5]} {Human: ENSG00000040608, RTN4R, reticulon 4 receptor, [Score=73.2, Expect=2e-13]} {Mouse: ENSMUSG00000111113, Rtn4r, reticulon 4 receptor, [Score=72.8, Expect=2e-13]; ENSMUSG00000043811, Rtn4r, reticulon 4 receptor, [Score=72.8, Expect=2e-13]} {Dmel: FBgn0004364, 18w, 18 wheeler, [Score=71.2, Expect=7e-13]} {Celegans: WBGene00001443, fli-1, Protein flightless-1 homolog, [Score=56.6, Expect=2e-08]} {Smed: dd_Smed_v6_12111_0_1, dd_Smed_v6_12111_0_1, [Score=48.1, Expect=8e-06]} {RNA1310_19257.1} {RNA815_9099} |
34. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 2.591 | - | - | - | 0.982 | 0.786 | 0.823 | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
35. | MligTC455_38284 | 12 | 0.25 | Mlig455_015813 | Neo: - Age: - |
2.59 | - | - | 0.803 | - | 0.974 | 0.813 | Mlig455_015813 {REF} {Length: 1163} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=61.6, Expect=2e-11]} {RNA1310_89599} {RNA815_16968} | |
36. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 2.587 | - | - | 0.779 | 0.974 | 0.834 | - | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
37. | MligTC455_39915 | 127 | 2.65 | Mlig455_002965 | Neo: - Age: Up-Down-Up |
HSPB1 | 2.574 | - | - | 0.864 | - | 0.954 | 0.756 | Mlig455_002965 {REF} {Length: 2866} {Pfam: Hsp20/alpha crystallin family [PF00011.23, score=48.1]} {Human: ENSG00000106211, HSPB1, heat shock protein family B (small) member 1, [RH, Score=53.1, Expect=1e-07]; ENSG00000152137, HSPB8, heat shock protein family B (small) member 8, [RH, Score=53.1, Expect=1e-07]} {Mouse: ENSMUSG00000041548, Hspb8, heat shock protein 8, [RH, Score=53.1, Expect=8e-08]} {Celegans: WBGene00002023, hsp-25, Heat Shock Protein, [RH, Score=70.1, Expect=9e-14]} {Smed: dd_Smed_v6_15128_0_2, dd_Smed_v6_15128_0_2, [Score=82.0, Expect=2e-17]} {RNA1509_23358} {RNA1310_19444} {RNA815_29507} |
38. | MligTC455_15881 | 222 | 4.62 | Mlig455_053354, Mlig455_053359 | Neo: - Age: - |
DCLK3 | 2.571 | - | - | 0.951 | 0.897 | - | 0.723 | Mlig455_053354 {REF} {Length: 5391} {Pfam: Protein kinase domain [PF00069.27, score=245.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.8]; Doublecortin [PF03607.19, score=83.2]} {Human: ENSG00000163673, DCLK3, doublecortin like kinase 3, [RH, Score=350, Expect=8e-109]; ENSG00000133083, DCLK1, doublecortin like kinase 1, [RH, Score=347, Expect=4e-110]; ENSG00000170390, DCLK2, doublecortin like kinase 2, [RH, Score=343, Expect=4e-105]} {Mouse: ENSMUSG00000032500, Dclk3, doublecortin-like kinase 3, [RH, Score=348, Expect=3e-106]; ENSMUSG00000027797, Dclk1, doublecortin-like kinase 1, [RH, Score=347, Expect=2e-106]; ENSMUSG00000028078, Dclk2, doublecortin-like kinase 2, [RH, Score=342, Expect=5e-105]} {Dmel: FBgn0261387, CG17528, [RH, Score=297, Expect=4e-88]} {Celegans: WBGene00000553, cmk-1, Calcium/calmodulin-dependent protein kinase type 1, [Score=258, Expect=3e-78]} {Smed: dd_Smed_v6_12689_0_1, dd_Smed_v6_12689_0_1, [RH, Score=347, Expect=6e-105]} {RNA1509_51067} {RNA1310_13514} {RNA815_32297} Mlig455_053359 {REF} {Length: 4205} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=245.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.8]; Doublecortin [PF03607.19, score=83.2]} {Human: ENSG00000163673, DCLK3, doublecortin like kinase 3, [RH, Score=350, Expect=8e-109]; ENSG00000133083, DCLK1, doublecortin like kinase 1, [RH, Score=347, Expect=4e-110]; ENSG00000170390, DCLK2, doublecortin like kinase 2, [RH, Score=343, Expect=4e-105]} {Mouse: ENSMUSG00000032500, Dclk3, doublecortin-like kinase 3, [RH, Score=348, Expect=3e-106]; ENSMUSG00000027797, Dclk1, doublecortin-like kinase 1, [RH, Score=347, Expect=2e-106]; ENSMUSG00000028078, Dclk2, doublecortin-like kinase 2, [RH, Score=342, Expect=5e-105]} {Dmel: FBgn0261387, CG17528, [RH, Score=297, Expect=4e-88]} {Celegans: WBGene00000553, cmk-1, Calcium/calmodulin-dependent protein kinase type 1, [Score=258, Expect=3e-78]} {Smed: dd_Smed_v6_12689_0_1, dd_Smed_v6_12689_0_1, [RH, Score=347, Expect=6e-105]} {RNA1509_51067} {RNA1310_13514, RNA1509_51067} {RNA1509_51067, RNA815_32297} |
39. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 2.562 | - | - | 0.828 | 0.975 | 0.759 | - | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
40. | MligTC455_16952 | 79 | 1.65 | Mlig455_001182 | Neo: - Age: - |
2.561 | - | - | 0.788 | 0.974 | 0.799 | - | Mlig455_001182 {REF} {Length: 3873} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [RH, Score=67.0, Expect=3e-14]} {RNA1509_4618} {RNA1310_46281} {RNA815_28578} | |
41. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
2.56 | - | - | 0.822 | 0.787 | - | 0.951 | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
42. | MligTC455_38368 | 107 | 2.24 | Mlig455_026435, Mlig455_044757 | Neo: - Age: Up-Down-Down |
SSUH2 | 2.555 | - | - | 0.746 | 0.956 | - | 0.853 | Mlig455_026435 {REF} {Length: 1789} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=233, Expect=1e-72]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [RH, Score=195, Expect=1e-58]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=117, Expect=3e-29]} {RNA1509_6425} {RNA1310_32434} {RNA815_16161} Mlig455_044757 {REF} {Length: 883} {TRANSSPLICED} {RNA1509_28356} {RNA1310_61125} {RNA815_53103} |
43. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
2.553 | - | - | - | 0.872 | 0.968 | 0.713 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
44. | MligTC455_15663 | 35 | 0.73 | Mlig455_062572 | Neo: - Age: logFC(26M/2M)=1.011 |
2.551 | - | - | 0.738 | 0.858 | 0.955 | - | Mlig455_062572 {REF} {Length: 1735} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1310_35902.2} {RNA815_33023} | |
45. | MligTC455_19456 | 34 | 0.7 | Mlig455_038677 | Neo: - Age: - |
2.541 | - | - | 0.815 | 0.763 | 0.963 | - | Mlig455_038677 {REF} {Length: 1621} {TRANSSPLICED} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [Score=49.3, Expect=4e-07]} {RNA1310_112748} | |
46. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 2.534 | - | - | 0.796 | 0.974 | 0.764 | - | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
47. | MligTC455_51537 | 225 | 4.69 | Mlig455_064569 | Neo: - Age: - |
2.531 | - | - | 0.812 | 0.977 | - | 0.742 | Mlig455_064569 {REF} {Length: 2141} {RNA1310_34295.1} {RNA815_22630} | |
48. | MligTC455_49877 | 188 | 3.91 | Mlig455_027465 | Neo: - Age: - Region-enriched R2: 3.005/0.04141 |
AC254952.1 | 2.498 | - | - | - | 0.973 | 0.790 | 0.735 | Mlig455_027465 {REF} {Length: 2059} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.0]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=6e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=144, Expect=9e-38]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=141, Expect=2e-36]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=1e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=6e-37]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=139, Expect=5e-36]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=134, Expect=2e-34]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=132, Expect=4e-33]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=126, Expect=6e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=131, Expect=2e-33]} {RNA1310_26175} {RNA815_7952} |
49. | MligTC455_11078 | 15 | 0.31 | Mlig455_045628 | Neo: - Age: - |
2.497 | - | - | 0.811 | 0.734 | 0.952 | - | Mlig455_045628 {REF} {Length: 2373} {Pfam: Polycystin cation channel [PF08016.14, score=25.4]} {RNA1310_39436.1} {RNA815_35444} | |
50. | MligTC455_29051 | 484 | 10.08 | Mlig455_064767 | Neo: - Age: - |
TMEM30A | 2.495 | - | - | 0.753 | 0.960 | - | 0.782 | Mlig455_064767 {REF} {Length: 2581} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=265.5]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [RH, Score=234, Expect=7e-73]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [RH, Score=241, Expect=6e-76]} {Dmel: FBgn0030752, CG9947, [RH, Score=294, Expect=8e-97]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=274, Expect=3e-89]} {RNA1509_38539, RNA1509_38955} {RNA1310_9371, RNA1509_38539, RNA1509_38955} {RNA1509_38539, RNA1509_38955, RNA815_12157} |
51. | MligTC455_31626 | 38 | 0.79 | Mlig455_032857 | Neo: - Age: - |
SLC23A1 | 2.493 | - | - | 0.821 | 0.957 | - | 0.715 | Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063} |
52. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
2.493 | - | - | 0.821 | 0.965 | - | 0.707 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
53. | MligTC455_18787 | 963 | 20.06 | Mlig455_014022 | Neo: - Age: - Region-enriched R2: 1.334/0.03482 |
STRC | 2.491 | - | - | - | 0.970 | 0.711 | 0.810 | Mlig455_014022 {REF} {Length: 5754} {Human: ENSG00000242866, STRC, stereocilin, [RH, Score=76.3, Expect=4e-13]} {Mouse: ENSMUSG00000033498, Strc, stereocilin, [RH, Score=80.9, Expect=1e-14]} {RNA1509_4378} {RNA1310_1493.1, RNA1509_4378} {RNA1509_4378, RNA815_804} |
54. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
2.481 | - | - | 0.783 | 0.963 | - | 0.735 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
55. | MligTC455_47094 | 240 | 5.01 | Mlig455_014204 | Neo: - Age: logFC(26M/2M)=-0.357 |
2.477 | - | - | 0.751 | 0.988 | 0.738 | - | Mlig455_014204 {REF} {Length: 3346} {Smed: dd_Smed_v6_4351_0_1, dd_Smed_v6_4351_0_1, [RH, Score=238, Expect=1e-74]} {RNA1509_35661} {RNA1310_8437, RNA1509_35661} {RNA1509_35661, RNA815_15552} | |
56. | MligTC455_03461 | 41 | 0.85 | Mlig455_008624, Mlig455_030301 | Neo: - Age: - |
2.474 | - | - | 0.745 | - | 0.972 | 0.757 | Mlig455_008624 {REF} {Length: 1156} {RNA1509_1367} {RNA1310_36629} {RNA815_34010} Mlig455_030301 {REF} {Length: 3265} {RNA1509_56822} {RNA1310_36629} {RNA815_1171.1} |
|
57. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 2.47 | - | - | 0.744 | 0.772 | 0.954 | - | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
58. | MligTC455_15598 | 45 | 0.94 | Mlig455_021461 | Neo: - Age: Down-Up-Up |
2.465 | - | - | - | 0.968 | 0.710 | 0.787 | Mlig455_021461 {REF} {Length: 2020} {RNA1310_35982.1} {RNA815_27626} | |
59. | MligTC455_17678 | 121 | 2.53 | Mlig455_036741 | Neo: - Age: - Region-enriched R2: 3.030/0.00234 Regeneration-downregulated R4: -3.160 Regeneration-depleted R4: -3.160 |
TNNC2 | 2.46 | - | - | 0.706 | 0.773 | 0.981 | - | Mlig455_036741 {REF} {Length: 924} {Pfam: EF-hand domain pair [PF13499.8, score=100.6]; EF-hand domain [PF13405.8, score=75.3]; EF hand [PF00036.34, score=73.4]; EF-hand domain pair [PF13833.8, score=55.4]; EF hand [PF13202.8, score=44.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=23.7]; EF-hand domain [PF14658.8, score=20.3]} {Human: ENSG00000101470, TNNC2, troponin C2, fast skeletal type, [Score=74.7, Expect=4e-17]} {Mouse: ENSMUSG00000017300, Tnnc2, troponin C2, fast, [Score=74.7, Expect=3e-17]} {Dmel: FBgn0040351, CG11638, [Score=68.6, Expect=5e-14]} {Celegans: WBGene00000286, cal-2, CALmodulin related genes; Calmodulin-like protein, [Score=72.0, Expect=3e-16]} {Smed: dd_Smed_v6_4669_0_1, dd_Smed_v6_4669_0_1, [Score=68.2, Expect=4e-15]} {RNA1310_42119} {RNA815_21011} |
60. | MligTC455_50045 | 52 | 1.09 | Mlig455_054573 | Neo: - Age: - |
2.46 | - | - | - | 0.773 | 0.952 | 0.735 | Mlig455_054573 {REF} {Length: 2684} {NoTransDecoderORF} {RNA1509_48232} {RNA1310_60087} {RNA815_14770.1} | |
61. | MligTC455_19280 | 21417 | 446.19 | Mlig455_057387, Mlig455_059547 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.621 Region-enriched R2: 3.570/0.00141 |
CHRNA10 | 2.454 | - | - | - | 0.967 | 0.776 | 0.711 | Mlig455_057387 {REF} {Length: 1088} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.5, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=95.5, Expect=4e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=94.0, Expect=2e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=109, Expect=6e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=97.4, Expect=5e-23]} {RNA1509_1306, RNA1509_1333, RNA1509_15501} {RNA1310_34970, RNA1509_1333, RNA1509_15501} {RNA1509_1333, RNA1509_15501, RNA815_15305.1} Mlig455_059547 {REF} {Length: 1084} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
62. | MligTC455_12970 | 132 | 2.76 | Mlig455_022445 | Neo: - Age: logFC(26M/2M)=-1.642 |
2.443 | - | - | 0.735 | 0.975 | 0.733 | - | Mlig455_022445 {REF} {Length: 1567} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=21.7]} {RNA1509_43359} {RNA1310_32360, RNA1509_43359} {RNA1509_43359, RNA815_34556} | |
63. | MligTC455_42579 | 1841 | 38.34 | Mlig455_061617 | Neo: - Age: - Region-enriched R7: 1.560/0.01513 Regeneration-downregulated BL: -2.445 Regeneration-depleted BL: -2.445 |
CAV2 | 2.432 | - | - | - | 0.962 | 0.739 | 0.731 | Mlig455_061617 {REF} {Length: 4295} {Pfam: Caveolin [PF01146.19, score=121.3]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=87.4, Expect=2e-22]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=90.1, Expect=1e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.2, Expect=1e-16]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=144, Expect=2e-45]} {RNA1509_24227} {RNA1310_41576, RNA1509_24227} {RNA1509_24227, RNA815_20166} |
64. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 2.411 | - | - | - | 0.951 | 0.738 | 0.722 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
65. | MligTC455_48986 | 511 | 10.64 | Mlig455_017301 | Neo: - Age: Down-Up-Down |
TRPM2 | 2.402 | - | - | 0.740 | 0.956 | - | 0.706 | Mlig455_017301 {REF} {Length: 4476} {Pfam: SLOG in TRPM [PF18139.3, score=216.0]; SLOG in TRPM, prokaryote [PF18171.3, score=64.9]; Ion transport protein [PF00520.33, score=58.5]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=420, Expect=4e-123]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=441, Expect=2e-130]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=293, Expect=2e-81]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=247, Expect=3e-66]} {Smed: dd_Smed_v6_13119_0_1, dd_Smed_v6_13119_0_1, [RH, Score=627, Expect=0.0]} {RNA1509_8528} {RNA1310_1728.1} {RNA815_888} |
66. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
2.381 | - | - | 0.717 | 0.950 | 0.714 | - | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
67. | MligTC455_51276 | 83 | 1.74 | Mlig455_014757, Mlig455_014817 | Neo: - Age: Down-Up-Down |
CTGF | 1.932 | - | - | - | 0.962 | - | 0.970 | Mlig455_014757 {REF} {Length: 2922} {Pfam: CCN3 Nov like TSP1 domain [PF19035.2, score=54.0]; Insulin-like growth factor binding protein [PF00219.20, score=36.3]; von Willebrand factor type C domain [PF00093.20, score=24.9]} {Human: ENSG00000118523, CTGF, connective tissue growth factor, [RH, Score=191, Expect=6e-57]} {Mouse: ENSMUSG00000019997, Ctgf, connective tissue growth factor, [RH, Score=182, Expect=1e-53]; ENSMUSG00000005124, Wisp1, WNT1 inducible signaling pathway protein 1, [RH, Score=180, Expect=9e-53]; ENSMUSG00000028195, Cyr61, cysteine rich protein 61, [RH, Score=179, Expect=2e-52]} {Dmel: FBgn0052183, Ccn, [RH, Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_18465_0_1, dd_Smed_v6_18465_0_1, [RH, Score=152, Expect=2e-42]} {RNA1310_28561} {RNA815_18173} Mlig455_014817 {REF} {Length: 2230} {Pfam: CCN3 Nov like TSP1 domain [PF19035.2, score=54.1]; Insulin-like growth factor binding protein [PF00219.20, score=36.3]; von Willebrand factor type C domain [PF00093.20, score=24.9]} {Human: ENSG00000118523, CTGF, connective tissue growth factor, [RH, Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000019997, Ctgf, connective tissue growth factor, [RH, Score=180, Expect=4e-53]; ENSMUSG00000005124, Wisp1, WNT1 inducible signaling pathway protein 1, [RH, Score=178, Expect=3e-52]; ENSMUSG00000028195, Cyr61, cysteine rich protein 61, [RH, Score=176, Expect=2e-51]} {Dmel: FBgn0052183, Ccn, [RH, Score=74.7, Expect=2e-14]} {Smed: dd_Smed_v6_18465_0_1, dd_Smed_v6_18465_0_1, [RH, Score=150, Expect=5e-42]} {RNA1310_28561} {RNA815_18173} |
68. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 1.909 | - | - | - | 0.952 | 0.957 | - | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
69. | MligTC455_33852 | 833 | 17.35 | Mlig455_009849, Mlig455_029790 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.367/0.00015 |
MGAT1, SLC24A3 | 1.904 | - | - | - | 0.969 | 0.935 | - | Mlig455_009849 {REF} {Length: 3524} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=160.6]} {Human: ENSG00000185052, SLC24A3, solute carrier family 24 member 3, [Score=173, Expect=5e-45]; ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [Score=172, Expect=2e-44]; ENSG00000140090, SLC24A4, solute carrier family 24 member 4, [Score=172, Expect=8e-45]} {Mouse: ENSMUSG00000041771, Slc24a4, solute carrier family 24 (sodium/potassium/calcium exchanger), member 4, [Score=171, Expect=6e-45]; ENSMUSG00000063873, Slc24a3, solute carrier family 24 (sodium/potassium/calcium exchanger), member 3, [Score=171, Expect=1e-44]; ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [Score=170, Expect=6e-44]} {Dmel: FBgn0028704, Nckx30C, [Score=163, Expect=4e-41]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=143, Expect=2e-35]} {Smed: dd_Smed_v6_9736_0_1, dd_Smed_v6_9736_0_1, [Score=310, Expect=2e-95]} {RNA1509_4329} {RNA1310_8845} {RNA815_2786.1} Mlig455_029790 {REF} {Length: 1524} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=152, Expect=5e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=3e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=171, Expect=2e-48]} {Celegans: WBGene00001638, gly-13, Putative alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, [Score=145, Expect=1e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=156, Expect=3e-43]} {RNA1310_114996} |
70. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
1.904 | - | - | - | 0.967 | 0.937 | - | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
71. | MligTC455_42486 | 52 | 1.09 | Mlig455_056354 | Neo: - Age: - |
1.902 | - | - | 0.929 | - | - | 0.973 | Mlig455_056354 {REF} {Length: 1240} | |
72. | MligTC455_13095 | 40 | 0.82 | Mlig455_036239 | Neo: - Age: - |
1.9 | - | - | - | 0.941 | 0.959 | - | Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130} | |
73. | MligTC455_40152 | 71 | 1.48 | Mlig455_044652 | Neo: - Age: - |
CALML3 | 1.898 | - | - | - | 0.915 | 0.983 | - | Mlig455_044652 {REF} {Length: 973} {Pfam: EF hand [PF00036.34, score=85.2]; EF-hand domain pair [PF13499.8, score=84.3]; EF-hand domain [PF13405.8, score=70.9]; EF-hand domain pair [PF13833.8, score=61.0]; EF hand [PF13202.8, score=51.9]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=36.6]; EF-hand domain [PF14658.8, score=21.5]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=94.0, Expect=2e-24]} {Mouse: ENSMUSG00000033765, Calm4, calmodulin 4, [Score=86.3, Expect=1e-21]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=76.3, Expect=7e-18]} {Celegans: WBGene00006583, tnc-2, Troponin C, isoform 2, [Score=63.5, Expect=4e-13]} {Smed: dd_Smed_v6_11942_0_1, dd_Smed_v6_11942_0_1, [Score=96.3, Expect=1e-25]} {RNA1310_41156} {RNA815_20058} |
74. | MligTC455_17960 | 44 | 0.92 | Mlig455_021047 | Neo: - Age: - Region-enriched R2: 4.515/0.04131 |
1.889 | - | - | 0.922 | - | 0.967 | - | Mlig455_021047 {REF} {Length: 2114} {Pfam: SH3 domain [PF17902.3, score=25.9]; Plectin repeat [PF00681.22, score=23.8]} {Smed: dd_Smed_v6_16329_0_1, dd_Smed_v6_16329_0_1, [Score=56.6, Expect=2e-08]} {RNA1509_53557} {RNA1310_11354} {RNA815_18566} | |
75. | MligTC455_42746 | 483 | 10.06 | Mlig455_040721 | Neo: - |
ACSF2 | 1.886 | - | - | - | 0.911 | 0.975 | - | Mlig455_040721 {REF} {Length: 3197} {Pfam: AMP-binding enzyme [PF00501.30, score=314.2]; AMP-binding enzyme C-terminal domain [PF13193.8, score=37.2]} {Human: ENSG00000167107, ACSF2, acyl-CoA synthetase family member 2, [Score=147, Expect=1e-37]} {Mouse: ENSMUSG00000076435, Acsf2, acyl-CoA synthetase family member 2, [Score=156, Expect=8e-41]} {Dmel: FBgn0027601, pdgy, pudgy, [Score=269, Expect=8e-83]} {Celegans: WBGene00008669, acs-14, Fatty Acid CoA Synthetase family, [Score=259, Expect=1e-79]} {Smed: dd_Smed_v6_10135_0_1, dd_Smed_v6_10135_0_1, [Score=317, Expect=5e-102]} {RNA1509_22715} {RNA1310_10057.2} {RNA815_14069} |
76. | MligTC455_03587 | 28 | 0.59 | Mlig455_032271, Mlig455_068492 | Neo: - Age: - Region-enriched R4: 6.165/0.03605 |
1.885 | - | - | - | - | 0.965 | 0.920 | Mlig455_032271 {REF} {Length: 453} {NoTransDecoderORF} Mlig455_068492 {REF} {Length: 473} {NoTransDecoderORF} |
|
77. | MligTC455_40555 | 4294 | 89.47 | Mlig455_028405, Mlig455_028439 | Neo: - Age: logFC(26M/2M)=0.704 Region-specific R2: 2.095 Region-enriched R2: 1.320/0.00861 Regeneration-depleted BL: -2.352 |
CALML3 | 1.885 | - | - | - | 0.968 | 0.917 | - | Mlig455_028405 {REF} {Length: 1039} {Pfam: EF-hand domain pair [PF13499.8, score=107.0]; EF-hand domain [PF13405.8, score=88.7]; EF hand [PF00036.34, score=85.4]; EF-hand domain pair [PF13833.8, score=63.1]; EF hand [PF13202.8, score=46.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.9]; EF-hand domain [PF14658.8, score=27.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.9]; Ca2+ insensitive EF hand [PF08726.12, score=22.1]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=94.0, Expect=1e-24]; ENSG00000143933, CALM2, calmodulin 2, [Score=93.2, Expect=3e-24]; ENSG00000198668, CALM1, calmodulin 1, [Score=93.2, Expect=3e-24]; ENSG00000160014, CALM3, calmodulin 3, [Score=93.2, Expect=3e-24]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=94.7, Expect=4e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=93.2, Expect=2e-24]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=93.2, Expect=2e-24]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=93.2, Expect=2e-24]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=90.5, Expect=2e-23]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=89.7, Expect=2e-23]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=89.7, Expect=2e-23]} {RNA1509_7376} {RNA1310_30171} {RNA815_22911} Mlig455_028439 {REF} {Length: 1042} {Pfam: EF-hand domain pair [PF13499.8, score=107.0]; EF-hand domain [PF13405.8, score=88.7]; EF hand [PF00036.34, score=85.4]; EF-hand domain pair [PF13833.8, score=63.1]; EF hand [PF13202.8, score=46.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.9]; EF-hand domain [PF14658.8, score=27.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.9]; Ca2+ insensitive EF hand [PF08726.12, score=22.1]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=94.0, Expect=1e-24]; ENSG00000143933, CALM2, calmodulin 2, [Score=93.2, Expect=3e-24]; ENSG00000198668, CALM1, calmodulin 1, [Score=93.2, Expect=3e-24]; ENSG00000160014, CALM3, calmodulin 3, [Score=93.2, Expect=3e-24]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=94.7, Expect=4e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=93.2, Expect=2e-24]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=93.2, Expect=2e-24]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=93.2, Expect=2e-24]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=90.5, Expect=2e-23]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=89.7, Expect=2e-23]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=89.7, Expect=2e-23]} {RNA1509_7376} {RNA1310_30171, RNA1509_7376} {RNA1509_7376, RNA815_22911} |
78. | MligTC455_29298 | 448 | 9.33 | Mlig455_054114 | Neo: - Age: - Region-enriched R2: 1.919/0.01506 |
1.881 | - | - | 0.930 | 0.951 | - | - | Mlig455_054114 {REF} {Length: 1799} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=39.1]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=171, Expect=3e-51]} {RNA1509_30304} {RNA1310_26220.2} {RNA815_9613} | |
79. | MligTC455_49774 | 201 | 4.18 | Mlig455_028574 | Neo: - Age: - Region-enriched R4: 12.872/0.00005 Regeneration-upregulated R3: 5.313 Regeneration-enriched R3: 5.313 |
1.874 | - | - | 0.952 | 0.922 | - | - | Mlig455_028574 {REF} {Length: 1498} {Pfam: Lectin C-type domain [PF00059.23, score=35.8]} {RNA1509_20946} {RNA1310_44606} {RNA815_35640} | |
80. | MligTC455_41308 | 97 | 2.02 | Mlig455_020613 | Neo: - Age: - |
1.872 | - | - | - | 0.953 | - | 0.919 | Mlig455_020613 {REF} {Length: 1386} {Pfam: BTB/POZ domain [PF00651.33, score=40.1]; BTB And C-terminal Kelch [PF07707.17, score=24.2]} {RNA1310_49711} {RNA815_50748} | |
81. | MligTC455_49671 | 22 | 0.45 | Mlig455_031821, Mlig455_047620, Mlig455_047673 | Neo: - Age: - |
1.87 | - | - | 0.911 | - | 0.959 | - | Mlig455_031821 {REF} {Length: 954} {Pfam: WSC domain [PF01822.21, score=56.5]; PAN domain [PF00024.28, score=20.4]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=54.7, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=53.9, Expect=2e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} Mlig455_047620 {REF} {Length: 1341} {Pfam: WSC domain [PF01822.21, score=54.9]; Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=21.1]; PAN domain [PF00024.28, score=19.0]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=55.8, Expect=6e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=54.7, Expect=8e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} Mlig455_047673 {REF} {Length: 1341} {Pfam: WSC domain [PF01822.21, score=54.9]; Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=21.1]; PAN domain [PF00024.28, score=19.0]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=55.8, Expect=6e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=54.7, Expect=8e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} |
|
82. | MligTC455_40554 | 2265 | 47.18 | Mlig455_028418 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.536 Region-specific R2: 2.078 Region-enriched R2: 1.385/0.00761 Regeneration-depleted BL: -2.309 |
CALML3 | 1.868 | - | - | - | 0.964 | 0.904 | - | Mlig455_028418 {REF} {Length: 966} {Pfam: EF-hand domain pair [PF13499.8, score=107.0]; EF-hand domain [PF13405.8, score=88.7]; EF hand [PF00036.34, score=85.4]; EF-hand domain pair [PF13833.8, score=63.1]; EF hand [PF13202.8, score=46.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.9]; EF-hand domain [PF14658.8, score=27.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.9]; Ca2+ insensitive EF hand [PF08726.12, score=22.1]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=94.0, Expect=1e-24]; ENSG00000143933, CALM2, calmodulin 2, [Score=93.2, Expect=3e-24]; ENSG00000198668, CALM1, calmodulin 1, [Score=93.2, Expect=3e-24]; ENSG00000160014, CALM3, calmodulin 3, [Score=93.2, Expect=3e-24]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=94.7, Expect=4e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=93.2, Expect=2e-24]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=93.2, Expect=2e-24]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=93.2, Expect=2e-24]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=90.5, Expect=2e-23]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=89.7, Expect=2e-23]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=89.7, Expect=2e-23]} {RNA1509_2799, RNA1509_7376} {RNA1310_30171, RNA1509_2799} {RNA1509_2799, RNA815_22911} |
83. | MligTC455_44301 | 1697 | 35.36 | Mlig455_000545 | Neo: - Age: - |
1.868 | - | - | - | 0.954 | 0.914 | - | Mlig455_000545 {REF} {Length: 1706} {TRANSSPLICED} {Smed: dd_Smed_v6_6108_0_1, dd_Smed_v6_6108_0_1, [RH, Score=190, Expect=9e-63]} {RNA1509_16536, RNA1509_27118, RNA1509_9934} {RNA1310_30744, RNA1509_16536, RNA1509_27118, RNA1509_9934} {RNA1509_16536, RNA1509_27118, RNA1509_9934, RNA815_13864} | |
84. | MligTC455_26585 | 173 | 3.61 | Mlig455_061024 | Neo: - Age: - |
1.867 | - | - | - | 0.950 | 0.917 | - | Mlig455_061024 {REF} {Length: 2825} {RNA1509_19437} {RNA1310_38787} {RNA815_16416} | |
85. | MligTC455_18451 | 118 | 2.46 | Mlig455_031824, Mlig455_047676 | Neo: - Age: - |
WSCD2 | 1.865 | - | - | - | 0.905 | 0.960 | - | Mlig455_031824 {REF} {Length: 1015} {Pfam: WSC domain [PF01822.21, score=53.3]; PAN domain [PF00024.28, score=21.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=63.2, Expect=6e-11]} {RNA1509_53783} {RNA1310_58580.1} {RNA815_46263} Mlig455_047676 {REF} {Length: 926} {Pfam: WSC domain [PF01822.21, score=57.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=64.3, Expect=2e-11]} {Mouse: ENSMUSG00000020811, Wscd1, WSC domain containing 1, [Score=49.3, Expect=1e-06]} {RNA1310_58580.1} |
86. | MligTC455_18323 | 168 | 3.5 | Mlig455_021183, Mlig455_057885 | Neo: - Age: logFC(26M/2M)=-0.384 Region-enriched R2: 3.394/0.02680 |
1.864 | - | - | - | 0.913 | 0.951 | - | Mlig455_021183 {REF} {Length: 3969} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=24.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=221, Expect=7e-62]} {RNA1509_9124} {RNA1310_5268.1} {RNA815_1717.1} Mlig455_057885 {REF} {Length: 4416} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=24.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=221, Expect=1e-61]} {RNA1509_9124} {RNA1310_5268.1} {RNA815_1717.1} |
|
87. | MligTC455_37051 | 372 | 7.75 | Mlig455_036602, Mlig455_036642 | Neo: - |
DNAH7 | 1.857 | - | - | - | 0.970 | - | 0.887 | Mlig455_036602 {REF} {Length: 11684} {TRANSSPLICED} {Pfam: Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=514.7]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=397.8]; P-loop containing dynein motor region [PF12775.9, score=249.2]; Dynein heavy chain AAA lid domain [PF17852.3, score=89.9]; AAA domain (dynein-related subfamily) [PF07728.16, score=55.6]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=29.8]; AAA domain [PF13401.8, score=22.7]; RNA helicase [PF00910.24, score=22.3]; AAA ATPase domain [PF13191.8, score=20.1]} {Human: ENSG00000118997, DNAH7, dynein axonemal heavy chain 7, [Score=1815, Expect=0.0]} {Mouse: ENSMUSG00000096141, Dnah7a, dynein, axonemal, heavy chain 7A, [Score=1810, Expect=0.0]; ENSMUSG00000101337, Dnah7c, dynein, axonemal, heavy chain 7C, [Score=1807, Expect=0.0]; ENSMUSG00000041144, Dnah7b, dynein, axonemal, heavy chain 7B, [Score=1800, Expect=0.0]} {Dmel: FBgn0013810, Dhc36C, Dynein heavy chain at 36C, [Score=1600, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=625, Expect=0.0]} {Smed: dd_Smed_v6_10846_0_1, dd_Smed_v6_10846_0_1, [Score=1468, Expect=0.0]} {RNA1509_8248} {RNA1310_99} {RNA815_595} Mlig455_036642 {REF} {Length: 12783} {TRANSSPLICED} {Pfam: Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=511.4]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=488.0]; Dynein heavy chain C-terminal domain [PF18199.3, score=380.3]; P-loop containing dynein motor region D4 [PF12780.9, score=368.2]; ATP-binding dynein motor region [PF12781.9, score=319.5]; P-loop containing dynein motor region [PF12775.9, score=278.9]; Dynein heavy chain AAA lid domain [PF18198.3, score=202.7]; Microtubule-binding stalk of dynein motor [PF12777.9, score=184.2]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=154.9]; Dynein heavy chain AAA lid domain [PF17852.3, score=107.4]; AAA+ lid domain [PF17857.3, score=72.9]; AAA domain (dynein-related subfamily) [PF07728.16, score=63.5]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=31.7]; AAA domain [PF13401.8, score=29.0]; AAA ATPase domain [PF13191.8, score=21.8]} {Human: ENSG00000118997, DNAH7, dynein axonemal heavy chain 7, [Score=5221, Expect=0.0]} {Mouse: ENSMUSG00000101337, Dnah7c, dynein, axonemal, heavy chain 7C, [Score=5215, Expect=0.0]; ENSMUSG00000041144, Dnah7b, dynein, axonemal, heavy chain 7B, [Score=5209, Expect=0.0]; ENSMUSG00000096141, Dnah7a, dynein, axonemal, heavy chain 7A, [Score=5197, Expect=0.0]} {Dmel: FBgn0013810, Dhc36C, Dynein heavy chain at 36C, [RH, Score=4322, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=709, Expect=0.0]} {Smed: dd_Smed_v6_5350_0_1, dd_Smed_v6_5350_0_1, [RH, Score=4284, Expect=0.0]} {RNA1509_8248} {RNA1310_99} {RNA815_595} |
88. | MligTC455_46052 | 159 | 3.31 | Mlig455_020714 | Neo: - Age: - Region-enriched R2: 2.603/0.01508 |
TRAF5 | 1.854 | - | - | - | 0.972 | - | 0.882 | Mlig455_020714 {REF} {Length: 919} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=73.6, Expect=8e-15]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=98.6, Expect=1e-23]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=135, Expect=1e-36]} {RNA1310_36792.1} {RNA815_40908} |
89. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 1.851 | - | - | - | 0.893 | 0.958 | - | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
90. | MligTC455_10719 | 61 | 1.26 | Mlig455_041088 | Neo: - Age: - |
1.848 | - | - | - | - | 0.982 | 0.866 | Mlig455_041088 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_18998} | |
91. | MligTC455_18322 | 82 | 1.71 | Mlig455_021228 | Neo: - |
1.848 | - | - | - | 0.889 | 0.959 | - | Mlig455_021228 {REF} {Length: 3954} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=26.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=229, Expect=2e-64]} {RNA1509_9124} {RNA1310_5268.1, RNA1509_9124} {RNA1509_9124, RNA815_1717.1} | |
92. | MligTC455_43525 | 62 | 1.29 | Mlig455_041078 | Neo: - Age: - |
1.844 | - | - | - | 0.867 | 0.977 | - | Mlig455_041078 {REF} {Length: 3896} {RNA1509_39963} {RNA1310_38466} {RNA815_23614} | |
93. | MligTC455_43663 | 88 | 1.83 | Mlig455_070157 | Neo: - Age: Up-Down-Up |
1.842 | - | - | - | 0.885 | 0.957 | - | Mlig455_070157 {REF} {Length: 2611} {RNA1310_65373} {RNA815_37965} | |
94. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 1.838 | - | - | 0.882 | 0.956 | - | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
95. | MligTC455_39180 | 256 | 5.34 | Mlig455_057231 | Neo: - Age: logFC(26M/2M)=-0.449 |
TCTE3 | 1.836 | - | - | - | 0.878 | 0.958 | - | Mlig455_057231 {REF} {Length: 1057} {Pfam: Tctex-1 family [PF03645.15, score=43.3]} {Human: ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.2, Expect=2e-11]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=59.3, Expect=1e-10]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=59.3, Expect=1e-10]; ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=58.5, Expect=2e-10]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.4, Expect=2e-23]} {RNA1509_34873, RNA1509_48552} {RNA1310_34743, RNA1509_34873, RNA1509_48552} {RNA1509_34873, RNA1509_48552, RNA815_18661} |
96. | MligTC455_16060 | 22 | 0.47 | Mlig455_044243 | Neo: - Age: Down-Up-Down |
CFAP157 | 1.835 | - | - | - | 0.861 | 0.974 | - | Mlig455_044243 {REF} {Length: 2694} {TRANSSPLICED} {Pfam: Siphovirus Gp157 [PF05565.13, score=20.7]; Protein of unknown function, DUF573 [PF04504.16, score=20.6]} {Human: ENSG00000160401, CFAP157, cilia and flagella associated protein 157, [Score=106, Expect=5e-24]} {Mouse: ENSMUSG00000038987, Cfap157, cilia and flagella associated protein 157, [Score=110, Expect=3e-25]} {Dmel: FBgn0036962, CG17122, [Score=67.8, Expect=1e-11]} {Smed: dd_Smed_v6_11523_0_1, dd_Smed_v6_11523_0_1, [Score=60.8, Expect=1e-09]} {RNA1509_42697} {RNA1310_10711, RNA1509_42697} {RNA1509_42697, RNA815_24261} |
97. | MligTC455_47244 | 216 | 4.49 | Mlig455_016130 | Neo: - Age: - Region-enriched R2: 3.391/0.02151 |
1.834 | - | - | - | 0.873 | 0.961 | - | Mlig455_016130 {REF} {Length: 3312} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=27.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.5]} {Smed: dd_Smed_v6_24733_0_1, dd_Smed_v6_24733_0_1, [RH, Score=231, Expect=1e-71]} {RNA1509_41111} {RNA1310_18481.1} {RNA815_10445} | |
98. | MligTC455_35487 | 3520 | 73.32 | Mlig455_001084, Mlig455_001093 | Neo: - Age: logFC(26M/2M)=-0.320 Region-specific R2: 1.362 |
1.833 | - | - | - | 0.882 | 0.951 | - | Mlig455_001084 {REF} {Length: 3041} {TRANSSPLICED} {Pfam: Acetyl-CoA hydrolase/transferase C-terminal domain [PF13336.8, score=193.8]; Acetyl-CoA hydrolase/transferase N-terminal domain [PF02550.17, score=88.7]} {Dmel: FBgn0039737, CG7920, [RH, Score=523, Expect=0.0]} {Celegans: WBGene00016630, acer-1, ACEtyl-CoA Regulator, [RH, Score=505, Expect=3e-177]} {Smed: dd_Smed_v6_1775_0_1, dd_Smed_v6_1775_0_1, [RH, Score=602, Expect=0.0]} {RNA1509_2322, RNA1509_28495} {RNA1310_12077.1, RNA1509_2322, RNA1509_28495} {RNA1509_2322, RNA1509_28495, RNA815_3460.1} Mlig455_001093 {REF} {Length: 2952} {TRANSSPLICED} {Pfam: Acetyl-CoA hydrolase/transferase C-terminal domain [PF13336.8, score=192.4]; Acetyl-CoA hydrolase/transferase N-terminal domain [PF02550.17, score=88.7]} {Dmel: FBgn0039737, CG7920, [RH, Score=520, Expect=0.0]} {Celegans: WBGene00016630, acer-1, ACEtyl-CoA Regulator, [RH, Score=502, Expect=6e-176]} {Smed: dd_Smed_v6_1775_0_1, dd_Smed_v6_1775_0_1, [RH, Score=606, Expect=0.0]} {RNA1509_11903, RNA1509_27965} {RNA1310_12077.2, RNA1509_11903, RNA1509_27965} {RNA1509_11903, RNA1509_27965, RNA815_3460.1} |
|
99. | MligTC455_35943 | 122 | 2.55 | Mlig455_062123 | Neo: - |
FEZF2 | 1.832 | - | - | - | 0.855 | 0.977 | - | Mlig455_062123 {REF} {Length: 3163} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=87.7]; Zinc-finger double domain [PF13465.8, score=71.3]; C2H2-type zinc finger [PF13894.8, score=56.0]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=25.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=23.1]; C2H2-type zinc finger [PF13912.8, score=21.6]} {Human: ENSG00000153266, FEZF2, FEZ family zinc finger 2, [RH, Score=337, Expect=3e-107]; ENSG00000128610, FEZF1, FEZ family zinc finger 1, [RH, Score=330, Expect=6e-105]} {Mouse: ENSMUSG00000021743, Fezf2, Fez family zinc finger 2, [RH, Score=341, Expect=7e-109]; ENSMUSG00000029697, Fezf1, Fez family zinc finger 1, [RH, Score=330, Expect=1e-104]} {Dmel: FBgn0031375, erm, earmuff, [RH, Score=343, Expect=2e-107]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [RH, Score=293, Expect=5e-94]} {Smed: dd_Smed_v6_26394_0_1, dd_Smed_v6_26394_0_1, [RH, Score=287, Expect=9e-92]} {RNA1310_14572} {RNA815_32467} |
100. | MligTC455_22804 | 350 | 7.3 | Mlig455_067193 | Neo: - Age: logFC(26M/2M)=-0.439 Region-enriched R2: 2.883/0.00412 |
TEKT3 | 1.83 | - | - | - | 0.863 | 0.967 | - | Mlig455_067193 {REF} {Length: 4067} {Pfam: Tektin family [PF03148.16, score=437.3]; fzo-like conserved region [PF04799.15, score=18.2]} {Human: ENSG00000125409, TEKT3, tektin 3, [Score=358, Expect=6e-119]} {Mouse: ENSMUSG00000042189, Tekt3, tektin 3, [Score=342, Expect=6e-113]} {Dmel: FBgn0052820, CG32820, [Score=286, Expect=5e-91]} {Smed: dd_Smed_v6_6511_0_1, dd_Smed_v6_6511_0_1, [RH, Score=552, Expect=0.0]} {RNA1509_7137} {RNA1310_13532} {RNA815_5924} |